Vital Signs The Analyst's Perspective - July 2015 Issue

Vital Signs The Analyst's Perspective - July 2015 Issue

Asia Pacific
Research Code: 9A35-00-3B-00-00
SKU: HC02616-AP-MR_16738


Special Price $337.50 save 25 %

In stock


$337.50 save 25 %


Pay by invoice



This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers – How will Consumers Fare?, and Illumina's acquisition of GenoLogics.

Table of Contents

This month's issue

Related Research
This study presents an overview and analysis of the South Korean contract research organization (CRO) market. It provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and emerging trends. The study covers the complete life cycle of the CRO market, from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management. The research service also analyses market engineering measurements and research and development trends. The study period is 2014 (base year) to 2019.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-3B-00-00
Is Prebook No